Myriad to buy genetic testing company

29-05-2018

Myriad to buy genetic testing company

hynci / iStockphoto.com

Molecular diagnostics company Myriad Genetics has agreed to acquire Counsyl, a genetic screening company, for $375 million. 


Myriad Genetics, Counsyl, Mergers and Acquisitions, M&A, genetic testing, women’s health


LSIPR